Extracellular Matrix Encasement Structures and Methods
US-2015359939-A1 · Dec 17, 2015 · US
Method and system for treatment of biological tissue
US8962324B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8962324-B2 |
| Application number | US-201313916803-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 13, 2013 |
| Priority date | Jan 18, 2006 |
| Publication date | Feb 24, 2015 |
| Grant date | Feb 24, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A composition for reconstruction, replacement or repair of damaged or diseased biological tissue comprising an extracellular matrix (ECM) composition that includes an ECM scaffold component and a bioactive agent component. In a preferred embodiment, the ECM scaffold component comprises mesothelial tissue and the bioactive agent comprises a statin.
First claim
Opening claim text (preview).
What is claimed is: 1. A composition for treating damaged biological tissue, comprising: an extracellular matrix (ECM) composition comprising a bioremodelable component comprising acellular mesothelial tissue, said mesothelial tissue further comprising an exogenously added statin, said statin being linked to said mesothelial tissue, wherein, when said ECM composition is administered to damaged biological tissue, said statin interacts with said mesothelial tissue, wherein said ECM…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8962324B2 cover?
- A composition for reconstruction, replacement or repair of damaged or diseased biological tissue comprising an extracellular matrix (ECM) composition that includes an ECM scaffold component and a bioactive agent component. In a preferred embodiment, the ECM scaffold component comprises mesothelial tissue and the bioactive agent comprises a statin.
- Who is the assignee on this patent?
- Matheny Robert G, Cormatrix Cardiovascular Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K35/38. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).